Thu March 28

Gaining Through Weight Loss: The Opportunity for Investors as Ozempic, Mounjaro Tackle Obesity

Obesity is a U.S. and global public-health problem. The global obesity rate has nearly doubled since 1980, and the World Health Organization estimates that nearly 1 billion people (adults, adolescents,...

Mon October 23, 2023

Uncertainty dominates macro headlines, sidelining investors. 162 S&P 500 report this week, biggest week of 3Q23 season.

We discuss: There are widening uncertainties around Israel-Gaza, Washington, rates and EPS season.  This explains why investors are sidelined but we need to be mindful that markets bottom on bad...

Thu September 28, 2023

Upcoming Medicare Drug-Price Negotiations: An Investment Perspective

Many countries, among them Canada, Japan, the United Kingdom, Germany, and France, negotiate directly with pharmaceutical companies to set prices of vital prescription medications on behalf of their respective residents....

Thu July 20, 2023

Defensives finally strengthening as key Cycle date nears

MARKETS HAVE ENTERED A WINDOW FOR POTENTIAL SHORT-TERM TREND CHANGE, BUT DO NOT EXPECT MUCH SELLING UNTIL AUGUST.  NEAR-TERM, AN SPX-4500-4600 RANGE MIGHT HOLD INTO LAST COUPLE DAYS OF JULY...

Tue May 2, 2023

LIVE Technical Stock Analysis May 2023

Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute of analysis) and consider several...

Thu December 22, 2022

Happy Holidays !!  Homebuilders and Pharma stocks favored

Happy Holidays. Hope your holiday season proves safe, happy and healthy.  I will be taking the final week off to spend with my family during the holidays. There won’t be...

Wed June 1, 2022

Live Techincal Analysis May 2022

Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute of analysis) and consider several...

Fri May 6, 2022

Live Technical Analysis April 2022

Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute of analysis) and consider several...